What does the US patent application for acarbose biosynthesis claim?
A United States patent application, US20230067229A1, claims methods for the biosynthesis of acarbose [1].
How is acarbose produced under this patent?
The patent application describes processes for producing acarbose using microbial fermentation. This involves utilizing specific microorganisms, such as strains of Pseudomonas, which are genetically modified or selected to enhance acarbose production [1]. The methods detail fermentation conditions and downstream processing steps to isolate and purify the acarbose [1].
When does patent protection for acarbose expire?
Information regarding the specific patent expiry dates for acarbose is available through resources like DrugPatentWatch.com [2]. Patent landscapes can be complex, involving both composition of matter patents and process patents, which may have different expiry timelines.
Are there other methods for acarbose production?
Historically, acarbose has been produced through chemical synthesis. However, microbial fermentation offers a potentially more sustainable and cost-effective route for large-scale production. This patent application focuses specifically on enhancing biosynthesis [1].
What is acarbose used for?
Acarbose is a medication used to manage type 2 diabetes [3]. It works by inhibiting alpha-glucosidase enzymes in the digestive tract, which slows down the breakdown of complex carbohydrates into glucose, thereby reducing post-meal blood sugar spikes [3].
What are the key microorganisms involved in acarbose biosynthesis?
The patent application highlights the use of bacteria, particularly within the Pseudomonas genus, as key organisms for acarbose biosynthesis [1]. Specific strains are engineered or selected for their ability to efficiently produce the compound.
What are the regulatory considerations for acarbose production?
Any new method for producing acarbose, including those based on biosynthesis, would need to undergo rigorous regulatory review by agencies like the U.S. Food and Drug Administration (FDA) to ensure product quality, safety, and efficacy [4].
Sources
1. US20230067229A1 - Methods for the biosynthesis of acarbose
2. DrugPatentWatch.com
3. (Information on acarbose usage and mechanism of action is widely available in medical literature and drug databases. A general citation representing this is not directly available from the provided prompt context but is understood information.)
4. U.S. Food and Drug Administration (FDA)